Sophia Genetics SA
SOPH4.800USD
+0.200+4.35%
Handelsschluss 02/06, 16:00（ET）Kurse um 15 Minuten verzögert
325.67MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Sophia Genetics SA Unternehmen
SOPHiA GENETICS SA is a Switzerland-based company primarily engaged in the healthcare technology industry. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The Company has offices in Switzerland, France, and the United States and operates worldwide.
Sophia Genetics SA Informationen
BörsenkürzelSOPH
Name des UnternehmensSOPHiA GENETICS SA
IPO-datumJul 23, 2021
CEOCamblong (Jurgi)
Anzahl der mitarbeiter423
WertpapierartOrdinary Share
GeschäftsjahresendeJul 23
AddresseLa Piece 12
StadtROLLE
BörseNASDAQ OMX - NASDAQ BASIC
LandSwitzerland
PostleitzahlCH-1180
Telefon41216941060
Websitehttps://www.sophiagenetics.com/
BörsenkürzelSOPH
IPO-datumJul 23, 2021
CEOCamblong (Jurgi)
Führungskräfte von Sophia Genetics SA
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
2.65M
+194164.00%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
443.81K
+48309.00%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
396.61K
-17644.00%
Mr. Troy M. Cox
Mr. Troy M. Cox
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
234.25K
+48309.00%
Mr. Didier Hirsch
Mr. Didier Hirsch
Non-Executive Independent Director
Non-Executive Independent Director
133.93K
+59409.00%
Mr. Ross J Muken
Mr. Ross J Muken
President
President
128.13K
+66596.00%
Dr. Philippe Menu, M.D., Ph.D.
Dr. Philippe Menu, M.D., Ph.D.
Chief Medical Officer and Chief Product Officer
Chief Medical Officer and Chief Product Officer
39.60K
-2144.00%
Mr. Daan Van Well
Mr. Daan Van Well
Chief Legal and Compliance Officer
Chief Legal and Compliance Officer
--
--
Ms. Manuela Da Silva Valente
Ms. Manuela Da Silva Valente
Chief People Officer
Chief People Officer
--
--
Dr. Tomer Berkovitz, Ph.D.
Dr. Tomer Berkovitz, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
2.65M
+194164.00%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
443.81K
+48309.00%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
396.61K
-17644.00%
Mr. Troy M. Cox
Mr. Troy M. Cox
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
234.25K
+48309.00%
Mr. Didier Hirsch
Mr. Didier Hirsch
Non-Executive Independent Director
Non-Executive Independent Director
133.93K
+59409.00%
Mr. Ross J Muken
Mr. Ross J Muken
President
President
128.13K
+66596.00%
Umsatzaufteilung
Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
Rest of EMEA
6.63M
34.09%
France
3.12M
16.01%
United States
2.62M
13.45%
Italy
2.51M
12.89%
Spain
1.46M
7.48%
Andere
3.13M
16.08%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Aktionärsstatistik
Aktualisiert: Sun, Feb 1
Aktualisiert: Sun, Feb 1
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Alychlo NV
10.31%
Generation Investment Management LLP
10.01%
aMoon Fund
8.12%
Akre Capital Management, LLC
5.48%
Balderton Capital (UK) LLP
4.96%
Andere
61.13%
Aktionäre
Aktionäre
Anteil
Alychlo NV
10.31%
Generation Investment Management LLP
10.01%
aMoon Fund
8.12%
Akre Capital Management, LLC
5.48%
Balderton Capital (UK) LLP
4.96%
Andere
61.13%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor/Hedge Fund
16.43%
Venture Capital
13.08%
Family Office
10.36%
Investment Advisor
8.51%
Individual Investor
6.43%
Hedge Fund
1.06%
Bank and Trust
0.46%
Research Firm
0.06%
Pension Fund
0.03%
Andere
43.58%
Institutionelle Beteiligung
Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
81
26.90M
39.65%
-12.60M
2025Q3
76
26.89M
39.64%
-8.96M
2025Q2
89
36.69M
54.29%
-200.15K
2025Q1
93
36.63M
54.82%
-389.48K
2024Q4
93
32.50M
49.36%
-965.83K
2024Q3
91
34.60M
52.08%
+657.87K
2024Q2
92
32.44M
48.93%
+1.33M
2024Q1
93
31.91M
48.51%
+375.11K
2023Q4
91
30.61M
46.76%
-676.23K
2023Q3
91
30.34M
46.61%
-4.34M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Alychlo NV
6.99M
10.31%
--
--
Feb 15, 2025
Generation Investment Management LLP
6.79M
10.01%
--
--
Sep 30, 2025
aMoon Fund
5.51M
8.12%
+577.36K
+11.70%
Feb 15, 2025
Akre Capital Management, LLC
3.72M
5.48%
--
--
Sep 30, 2025
Balderton Capital (UK) LLP
3.36M
4.96%
--
--
Feb 15, 2025
Camblong (Jurgi)
2.65M
3.91%
+194.16K
+7.89%
Feb 15, 2025
Banque Pictet & Cie S.A.
2.21M
3.25%
--
--
Sep 30, 2025
Alta Wealth Advisors LLC
1.41M
2.08%
+1.41M
--
Sep 30, 2025
Principal Global Investors (Equity)
1.39M
2.05%
-8.95K
-0.64%
Sep 30, 2025
Ossipow (Vincent)
443.81K
0.65%
+48.31K
+12.21%
Feb 15, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
iShares Health Innovation Active ETF
0%
Fidelity Nasdaq Composite Index ETF
0%
iShares Health Innovation Active ETF
Anteil0%
Fidelity Nasdaq Composite Index ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
